Kodiak Sciences CMO and Chief Development Officer Dr. Jason Ehrlich resigns effective August 25, 2023

Kodiak Sciences Inc.

Resignation as Chief Medical Officer and Chief Development Officer effective August 25, 2023.
Resignation not due to any disagreement with the Company on operations, policies, or practices.
No successor named in the filing.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Jason Ehrlich

Chief Medical Officer and Chief Development Officer

KOD · Kodiak Sciences Inc.

Effective: 2023-08-25
Filed: August 17, 2023, 7:59 PM ET

On August 16, 2023, Jason Ehrlich, M.D., Ph.D., informed the Company of his resignation as Chief Medical Officer and Chief Development Officer of the Company, effective August 25, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jason Ehrlich resigned as Chief Medical Officer and Chief Development Officer at Kodiak Sciences Inc..

Action: resigned
Role: Chief Medical Officer and Chief Development Officer

Exact text from the filing

On August 16, 2023, Jason Ehrlich, M.D., Ph.D., informed the Company of his resignation as Chief Medical Officer and Chief Development Officer of the Company, effective August 25, 2023.

View on SEC.gov

Kodiak Sciences Inc. filing history →

Source: SEC EDGAR

accession 0000950170-23-043277

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.